Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05280509 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Telios Pharma, Inc. |
| Last Updated on CT.gov | February 21, 2023 (Feb 21, 2023) |
As of March 2, 2026: Clinical trial NCT05280509 is currently recruiting participants. This clinical trial study for myelofibrosis is actively seeking new participants at 4 locations across the United States. The study is sponsored by Telios Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05280509 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05280509 was last updated Feb 21, 2023 (February 21, 2023). HelloStudys verifies this status automatically.